Related Experiment Video
Updated: Oct 6, 2025

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome
Published on: November 30, 2022
Mosaic dysfunction of mitophagy in mitochondrial muscle disease
Takayuki Mito1, Amy E Vincent2, Julie Faitg2
1Research Program of Stem Cells and Metabolism, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, 00290 Helsinki, Finland.
Abstract:
Mitophagy is a quality control mechanism that eliminates damaged mitochondria, yet its significance in mammalian pathophysiology and aging has remained unclear. Here, we report that mitophagy contributes to mitochondrial dysfunction in skeletal muscle of aged mice and human patients. The early disease stage is characterized by muscle fibers with central nuclei, with enhanced mitophagy around these nuclei. However, progressive mitochondrial dysfunction halts mitophagy and disrupts lysosomal homeostasis. Interestingly, activated or halted mitophagy occur in a mosaic manner even in adjacent muscle fibers, indicating cell-autonomous regulation. Rapamycin restores mitochondrial turnover, indicating mTOR-dependence of mitochondrial recycling in advanced disease stage. Our evidence suggests that (1) mitophagy is a hallmark of age-related mitochondrial pathology in mammalian muscle, (2) mosaic halting of mitophagy is a mechanism explaining mosaic respiratory chain deficiency and accumulation of pathogenic mtDNA variants in adult-onset mitochondrial diseases and normal aging, and (3) augmenting mitophagy is a promising therapeutic approach for muscle mitochondrial dysfunction.
Insights
Mitophagy, the removal of damaged mitochondria, is key in aging muscle. Its dysfunction contributes to age-related muscle diseases, but boosting mitophagy may offer therapeutic benefits.
Area of Science:
- Cellular Biology
- Mitochondrial Biology
- Aging Research
Background:
- Mitophagy is a crucial mitochondrial quality control process.
- Its role in mammalian aging and pathophysiology is not fully understood.
- Mitochondrial dysfunction is a hallmark of aging and various diseases.
Purpose of the Study:
- To investigate the role of mitophagy in age-related skeletal muscle dysfunction.
- To elucidate the mechanisms underlying mitochondrial pathology in aging.
- To explore mitophagy as a potential therapeutic target.
Main Methods:
- Analysis of mitophagy in skeletal muscle of aged mice and human patients.
- Histological examination of muscle fibers and mitochondrial morphology.
- Assessment of lysosomal homeostasis and mitochondrial turnover.
- Investigating the effect of rapamycin on mitophagy.
Main Results:
- Mitophagy is enhanced in early stages of age-related muscle pathology, particularly around central nuclei.
- Progressive dysfunction leads to mitophagy arrest and disrupted lysosomal homeostasis.
- Mitophagy exhibits mosaic, cell-autonomous regulation in adjacent muscle fibers.
- Rapamycin treatment restored mitochondrial turnover, suggesting mTOR pathway involvement.
Conclusions:
- Mitophagy is a significant feature of age-related mitochondrial pathology in mammalian muscle.
- Mosaic mitophagy arrest contributes to respiratory chain deficiencies and mtDNA accumulation in aging and disease.
- Enhancing mitophagy presents a promising therapeutic strategy for muscle mitochondrial dysfunction.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Membranes
The Inner Mitochondrial Membrane
Mitochondria
Satellite Stem Cells and Muscular Dystrophy
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...

